#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition


ICON announces executive leadership transition

Staff Writer |
Dublin, Ireland - October 21, 2016, Dublin, Ireland - ICON plc, a provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, announced that Steve Cutler will be appointed as chief executive officer.

Dr. Cutler joined ICON in 2011 as President, ICON Clinical Research Services. He was promoted to ICON plc Chief Operating Officer in January 2014 and was appointed to the Board of Directors in November 2015.

Prior to joining ICON, Dr. Cutler was Chief Executive Officer of Kendle.

Prior to Kendle, he held various senior roles in both Quintiles and Sandoz (now Novartis).

Dr. Cutler holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

Ciaran Murray will transition to the role of Chairman of the Board of Directors.


Alkermes appoints two directors
Perrigo Company appoints Ray Silcock as chief financial officer
Glanbia appoints two independent non-executive directors
Cairn Homes appoints three independent non-executive directors
Independent News and Media appoints Kate Marsh as non-executive director

What to read next

ICON: Bruce Given new chairman
Aptuit names Jonathan Goldman as CEO
ICON appoints new board member